Nara Medical University: Clinical Trials

12 trials sponsored by Nara Medical University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 recruiting, 2 unknown, 1 terminated. 3 Phase 4, 2 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Terminated 1
Not applicable2Completed 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow Nara Medical University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Flow Patterns and Stent Thrombosis
Stent Thrombosis
CompletedQueen Mary University of London1202024-04-012026-10-02
AI-Powered Scoliosis Auto-Analysis System Multicenter Development and Validations
Nude back photo - Spinal Deformity
RecruitingThe University of Hong Kong25002022-05-012026-05-01
iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study
Bosutinib (Phase 1 part), Bosutinib (Phase 2 part) - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2CompletedKyoto University462019-03-192026-08-10
PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)
PGA felt reinforcement - Disease of Pancreatic or Periampullary Lesions
Phase 3CompletedUniversity of Toyama5142018-10-102026-05-05
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Bladder Cancer
RecruitingCedars-Sinai Medical Center9002016-12-302026-02-04
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Bladder Cancer
CompletedCedars-Sinai Medical Center4502016-12-302026-10-20
Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors
Hemophilia A With Inhibitor
UnknownNara Medical University102015-09-012015-09-18
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
Azilsartan, Valsartan - Hypertension
Phase 4CompletedNara Medical University702012-06-012013-10-30
Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy
Stapling closure of the pancreatic stump, Roux-en-Y anastomosis of the pancreatic stump - Pancreatic Cancer, Pancreatic Cystic Lesions
Not applicableCompletedWakayama Medical University1362011-06-012016-07-21
The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
Carperitide heart failure therapy, Standard heart failure therapy - Heart Failure, Renal Failure
Phase 4TerminatedNara Medical University2002009-05-012011-07-22
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
Angiotensin II Receptor Antagonists, Angiotensin-converting Enzyme Inhibitors - Brain Infarction, Hypertension
Phase 4CompletedNara Medical University3952004-05-012013-10-30
Hemofiltration for Contrast-Induced Nephropathy
hemofiltration - Chronic Kidney Disease, Cardiac Catheterization
Not applicableUnknownNara Medical University1002005-09-12

Conditions studied

Hypertension (2)  ·  Pancreatic Fistula (2)  ·  Urinary Bladder Neoplasms (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Brain Infarction (1)  ·  Cognitive Dysfunction (1)  ·  Congenital Abnormalities (1)  ·  Heart Failure (1)  ·  Hemophilia A (1)  ·  Pancreatic Neoplasms (1)  ·  Pancreatic Pseudocyst (1)  ·  Pancreatitis, Chronic (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Scoliosis (1)

Interventions

Angiotensin Receptor Antagonists (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Hemofiltration (1)  ·  Valsartan (1)  ·  azilsartan (1)  ·  bosutinib (1)

Countries

Japan (10)  ·  United States (2)  ·  Hong Kong (1)  ·  United Kingdom (1)

Top investigators

Yoshihiko Saito, MD, PhD (4)  ·  Charles Rosser, MD (2)  ·  Haruhisa Inoue (1)  ·  Hideki Furuya, MD (1)  ·  Hideki Furuya, PhD (1)  ·  Jason Pui Yin Cheung, MD, MS (1)  ·  Manabu Kawai, MD (1)  ·  Midori Shima, MD, PhD (1)  ·  Tsutomu Fujii, MD, PhD (1)

Results publications

PMID 38045238, PMID 38167321, PMID 16003309, PMID 20538249, PMID 21529927, PMID 23878017, PMID 26473652, PMID 31399139, PMID 36467452, PMID 39461864, PMID 40728222, PMID 42106837, PMID 42608795

NIH funding

R01CA198887 (2)